Common Contracts

CO-EXCLUSIVE LICENSE AGREEMENT BETWEEN THE UNIVERSITY OF CHICAGO AND ARIDIS PHARMACEUTICAL FOR STAPH ALPHA TOXIN TECHNOLOGY

Co-Exclusive License Agreement • July 18th, 2018 • Aridis Pharmaceuticals, Inc. • Pharmaceutical preparations

• Contract Type
  Co-Exclusive License Agreement
• Filed
  July 18th, 2018
• Company
  Aridis Pharmaceuticals, Inc.
• Industry
  Pharmaceutical preparations

This License Agreement (“Agreement”), dated June 13, 2017 (the “Effective Date”), is between The University of Chicago, an Illinois not-for-profit corporation (“University”), and Aridis Pharmaceuticals, Inc., a Delaware Corporation, having an address at 5941 Optical Court, San Jose, CA (“Company”). Each hereunder may be referred to separately as the “Party”, or together as the “Parties”.

CO-EXCLUSIVE LICENSE AGREEMENT BETWEEN THE UNIVERSITY OF CHICAGO AND ARIDIS PHARMACEUTICAL FOR STAPH ALPHA TOXIN TECHNOLOGY

Co-Exclusive License Agreement • April 20th, 2018 • Aridis Pharmaceuticals, Inc. • Pharmaceutical preparations

• Contract Type
  Co-Exclusive License Agreement
• Filed
  April 20th, 2018
• Company
  Aridis Pharmaceuticals, Inc.
• Industry
  Pharmaceutical preparations

This License Agreement (“Agreement”), dated June 13, 2017 (the “Effective Date”), is between The University of Chicago, an Illinois not-for-profit corporation (“University”), and Aridis Pharmaceuticals, Inc., a Delaware Corporation, having an address at 5941 Optical Court, San Jose, CA (“Company”). Each hereunder may be referred to separately as the “Party”, or together as the “Parties”.